These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1100729)

  • 1. Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.
    Weiss L; Glaves D
    J Immunol; 1975 Nov; 115(5):1362-5. PubMed ID: 1100729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologically mediated macrophage aggregation in monolayers of peritoneal cells from BCG-sensitized mice.
    Preston PM; Hart PD; Brown IN
    Immunology; 1977 Jan; 32(1):33-41. PubMed ID: 139359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation among mouse strains in responsiveness to migration inhibitory factor.
    Tagliabue A; Herberman RB; McCoy JL
    Cell Immunol; 1979 Jul; 45(2):464-8. PubMed ID: 380823
    [No Abstract]   [Full Text] [Related]  

  • 8. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotaxis of resident, elicited and immunologically activated murine peritoneal macrophages.
    Staer AF; Rhodes JM; Bennedsen J; Olesen Larsen S
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):117-21. PubMed ID: 6880746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
    Kato K; Yamamoto K
    Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mortality of cadmium-intoxicated mice infected with the BCG strain of Mycobacterium bovis.
    Bozelka BE; Burkholder PM
    J Reticuloendothel Soc; 1979 Sep; 26(3):229-37. PubMed ID: 387955
    [No Abstract]   [Full Text] [Related]  

  • 13. The requirement for macrophages in the augmentation of natural killer cell activity by BCG.
    Tracey DE
    J Immunol; 1979 Aug; 123(2):840-5. PubMed ID: 222845
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage fusion factor elicited from BGG-sensitized lymphocytes.
    Warfel AH; Hadden JW
    Am J Pathol; 1978 Dec; 93(3):753-70. PubMed ID: 362945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice.
    Matsumura H; Nakano M
    J Immunol; 1988 Jan; 140(2):494-500. PubMed ID: 3121747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modulation of macrophage tumoricidal activity: partial characterization of a macrophage-activating factor(s) in supernatants of NaIO4-treated peritoneal cells.
    Weinberg JB; Hibbs JB
    J Reticuloendothel Soc; 1979 Sep; 26(3):283-93. PubMed ID: 228037
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of sialic acid in the macrophage glycolipid receptor for MIF.
    Liu DY; Petschek KD; Remold HG; David JR
    J Immunol; 1980 Apr; 124(4):2042-7. PubMed ID: 6988512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse mononuclear cell chemotaxis: description of system.
    Boetcher DA; Meltzer MS
    J Natl Cancer Inst; 1975 Mar; 54(3):795-9. PubMed ID: 1091744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines.
    Poste G
    Cancer Res; 1975 Sep; 35(9):2558-66. PubMed ID: 167963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.